SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zenotech Laboratories submits board meeting intimation

16 Jan 2026 Evaluate
Zenotech Laboratories has informed that the meeting of the Board of Directors of Zenotech Laboratories is scheduled to be held on Friday, January 23, 2026, to consider and approve Unaudited Standalone Financial Results of the Company for the quarter and nine months ended December 31, 2025. Further to communication dated December 26, 2025, the Trading Window has been closed from Thursday, January 01, 2026 and will remain closed until Sunday, January 25, 2026 i.e. after 48 hours of the declaration of financial results.

The above information is a part of company’s filings submitted to BSE.

Zenotech Laboratorie Share Price

46.54 -0.92 (-1.94%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×